{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T03:31:20Z","timestamp":1773804680918,"version":"3.50.1"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04003-w","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T10:33:52Z","timestamp":1748601232000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Helicobacter pylori is associated with less tumor-infiltrating lymphocytes and a poor prognosis in gastric cancer"],"prefix":"10.1186","volume":"25","author":[{"given":"Zetian","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongxin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingya","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengpei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengjun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongda","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zekuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"issue":"3","key":"4003_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"4003_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"4003_CR3","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1023\/A:1008243606668","volume":"8","author":"B Glimelius","year":"1997","unstructured":"Glimelius B, Ekstrom K, Hoffman K, Graf W, Sjoden PO, Haglund U, Svensson C, Enander LK, Linne T, Sellstrom H, et al. Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. Annals Oncology: Official J Eur Soc Med Oncol. 1997;8(2):163\u20138.","journal-title":"Annals Oncology: Official J Eur Soc Med Oncol"},{"issue":"6","key":"4003_CR4","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1002\/jso.25220","volume":"118","author":"P Li","year":"2018","unstructured":"Li P, Huang CM, Zheng CH, Russo A, Kasbekar P, Brennan MF, Coit DG, Strong VE. Comparison of gastric cancer survival after R0 resection in the US and China. J Surg Oncol. 2018;118(6):975\u201382.","journal-title":"J Surg Oncol"},{"issue":"1","key":"4003_CR5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1634\/theoncologist.2018-0221","volume":"24","author":"L Fashoyin-Aje","year":"2018","unstructured":"Fashoyin-Aje L, Donoghue M, Chen H, He K, Veeraraghavan J, Goldberg KB, Keegan P, McKee AE, Pazdur R. FDA approval summary: pembrolizumab for recurrent locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma expressing PD\u2010L1. Oncologist. 2018;24(1):103\u20139.","journal-title":"Oncologist"},{"issue":"10294","key":"4003_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","volume":"398","author":"YY Janjigian","year":"2021","unstructured":"Janjigian YY, Shitara K, Moehler M, Garrido M, Salman P, Shen L, Wyrwicz L, Yamaguchi K, Skoczylas T, Campos Bragagnoli A, et al. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial. Lancet (London England). 2021;398(10294):27\u201340.","journal-title":"Lancet (London England)"},{"key":"4003_CR7","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.canlet.2019.11.009","volume":"470","author":"X Lei","year":"2020","unstructured":"Lei X, Lei Y, Li JK, Du WX, Li RG, Yang J, Li J, Li F, Tan HB. Immune cells within the tumor microenvironment: biological functions and roles in cancer immunotherapy. Cancer Lett. 2020;470:126\u201333.","journal-title":"Cancer Lett"},{"issue":"8","key":"4003_CR8","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/s41591-019-0522-3","volume":"25","author":"KE Yost","year":"2019","unstructured":"Yost KE, Satpathy AT, Wells DK, Qi Y, Wang C, Kageyama R, McNamara KL, Granja JM, Sarin KY, Brown RA, et al. Clonal replacement of tumor-specific T cells following PD-1 Blockade. Nat Med. 2019;25(8):1251\u20139.","journal-title":"Nat Med"},{"key":"4003_CR9","doi-asserted-by":"crossref","unstructured":"Lin B, Du L, Li H, Zhu X, Cui L, Li XJB. Biomedecine P, pharmacotherapie: Tumor-infiltrating lymphocytes: warriors fight against tumors powerfully. 2020, 132:110873.","DOI":"10.1016\/j.biopha.2020.110873"},{"key":"4003_CR10","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1146\/annurev.iy.06.040188.003213","volume":"6","author":"H Clevers","year":"1988","unstructured":"Clevers H, Alarcon B, Wileman T, Terhorst C. The T cell receptor\/CD3 complex: a dynamic protein ensemble. Annu Rev Immunol. 1988;6:629\u201362.","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"4003_CR11","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00262-020-02694-6","volume":"70","author":"S Yun","year":"2021","unstructured":"Yun S, Koh J, Nam SK, Kwak Y, Ahn SH, Do Park J, Kim HH, Kim WH, Lee HS. Immunoscore is a strong predictor of survival in the prognosis of stage II\/III gastric cancer patients following 5-FU-based adjuvant chemotherapy. Cancer Immunol Immunotherapy: CII. 2021;70(2):431\u201341.","journal-title":"Cancer Immunol Immunotherapy: CII"},{"issue":"6","key":"4003_CR12","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.4049\/jimmunol.162.6.3574","volume":"162","author":"H Tanaka","year":"1999","unstructured":"Tanaka H, Yoshizawa H, Yamaguchi Y, Ito K, Kagamu H, Suzuki E, Gejyo F, Hamada H, Arakawa M. Successful adoptive immunotherapy of murine poorly Immunogenic tumor with specific effector cells generated from gene-modified tumor-primed lymph node cells. J Immunol (Baltimore Md: 1950). 1999;162(6):3574\u201382.","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"4003_CR13","doi-asserted-by":"crossref","unstructured":"Mahmoud S, Paish E, Powe D, Macmillan R, Grainge M, Lee A, Ellis I. Green AJJocoojotASoCO: Tumor-infiltrating CD8\u2009+\u2009lymphocytes predict clinical outcome in breast cancer. 2011, 29(15):1949\u20131955.","DOI":"10.1200\/JCO.2010.30.5037"},{"issue":"5795","key":"4003_CR14","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1126\/science.1129139","volume":"313","author":"J Galon","year":"2006","unstructured":"Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pag\u00e8s C, Tosolini M, Camus M, Berger A, Wind P, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Sci (New York NY). 2006;313(5795):1960\u20134.","journal-title":"Sci (New York NY)"},{"issue":"7","key":"4003_CR15","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1158\/1078-0432.CCR-13-2830","volume":"20","author":"MG Anitei","year":"2014","unstructured":"Anitei MG, Zeitoun G, Mlecnik B, Marliot F, Haicheur N, Todosi AM, Kirilovsky A, Lagorce C, Bindea G, Ferariu D, et al. Prognostic and predictive values of the immunoscore in patients with rectal cancer. Clin cancer Research: Official J Am Association Cancer Res. 2014;20(7):1891\u20139.","journal-title":"Clin cancer Research: Official J Am Association Cancer Res"},{"issue":"7550","key":"4003_CR16","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nature14395","volume":"521","author":"S Shalapour","year":"2015","unstructured":"Shalapour S, Font-Burgada J, Di Caro G, Zhong Z, Sanchez-Lopez E, Dhar D, Willimsky G, Ammirante M, Strasner A, Hansel DE, et al. Immunosuppressive plasma cells impede T-cell-dependent Immunogenic chemotherapy. Nature. 2015;521(7550):94\u20138.","journal-title":"Nature"},{"issue":"3","key":"4003_CR17","doi-asserted-by":"publisher","first-page":"661","DOI":"10.4143\/crt.2019.718","volume":"52","author":"Y Park","year":"2020","unstructured":"Park Y, Koh J, Na HY, Kwak Y, Lee KW, Ahn SH, Park DJ, Kim HH, Lee HS. PD-L1 testing in gastric Cancer by the combined positive score of the 22C3 pharmdx and SP263 assay with clinically relevant Cut-offs. Cancer Res Treat. 2020;52(3):661\u201370.","journal-title":"Cancer Res Treat"},{"issue":"1","key":"4003_CR18","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41392-021-00784-0","volume":"6","author":"J Chen","year":"2021","unstructured":"Chen J, Lin Z, Liu L, Zhang R, Geng Y, Fan M, Zhu W, Lu M, Lu L, Jia H, et al. GOLM1 exacerbates CD8(+) T cell suppression in hepatocellular carcinoma by promoting Exosomal PD-L1 transport into tumor-associated macrophages. Signal Transduct Target Therapy. 2021;6(1):397.","journal-title":"Signal Transduct Target Therapy"},{"issue":"127","key":"4003_CR19","doi-asserted-by":"publisher","first-page":"127ra137","DOI":"10.1126\/scitranslmed.3003689","volume":"4","author":"JM Taube","year":"2012","unstructured":"Taube JM, Anders RA, Young GD, Xu H, Sharma R, McMiller TL, Chen S, Klein AP, Pardoll DM, Topalian SL, et al. Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape. Sci Transl Med. 2012;4(127):127ra137.","journal-title":"Sci Transl Med"},{"issue":"17","key":"4003_CR20","doi-asserted-by":"publisher","first-page":"3969","DOI":"10.1158\/1078-0432.CCR-15-0244","volume":"21","author":"JM Taube","year":"2015","unstructured":"Taube JM, Young GD, McMiller TL, Chen S, Salas JT, Pritchard TS, Xu H, Meeker AK, Fan J, Cheadle C, et al. Differential expression of Immune-Regulatory genes associated with PD-L1 display in melanoma: implications for PD-1 pathway Blockade. Clin cancer Research: Official J Am Association Cancer Res. 2015;21(17):3969\u201376.","journal-title":"Clin cancer Research: Official J Am Association Cancer Res"},{"issue":"1","key":"4003_CR21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/labinvest.2013.130","volume":"94","author":"V Velcheti","year":"2014","unstructured":"Velcheti V, Schalper KA, Carvajal DE, Anagnostou VK, Syrigos KN, Sznol M, Herbst RS, Gettinger SN, Chen L, Rimm DL. Programmed death ligand-1 expression in non-small cell lung cancer. Lab Invest. 2014;94(1):107\u201316.","journal-title":"Lab Invest"},{"key":"4003_CR22","doi-asserted-by":"crossref","unstructured":"Zhang L, Chen Y, Wang H, Xu Z, Wang Y, Li S, Liu J, Chen Y, Luo H, Wu L et al. Massive PD-L1 and CD8 double positive TILs characterize an immunosuppressive microenvironment with high mutational burden in lung cancer. J Immunother Cancer 2021, 9(6).","DOI":"10.1136\/jitc-2021-002356"},{"issue":"5","key":"4003_CR23","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1136\/gutjnl-2015-310839","volume":"66","author":"ED Thompson","year":"2017","unstructured":"Thompson ED, Zahurak M, Murphy A, Cornish T, Cuka N, Abdelfatah E, Yang S, Duncan M, Ahuja N, Taube JM, et al. Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma. Gut. 2017;66(5):794\u2013801.","journal-title":"Gut"},{"issue":"1","key":"4003_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.acthis.2006.01.003","volume":"108","author":"C Wu","year":"2006","unstructured":"Wu C, Zhu Y, Jiang J, Zhao J, Zhang XG, Xu N. Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance. Acta Histochem. 2006;108(1):19\u201324.","journal-title":"Acta Histochem"},{"issue":"8","key":"4003_CR25","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1158\/1078-0432.CCR-04-1469","volume":"11","author":"Y Ohigashi","year":"2005","unstructured":"Ohigashi Y, Sho M, Yamada Y, Tsurui Y, Hamada K, Ikeda N, Mizuno T, Yoriki R, Kashizuka H, Yane K, et al. Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer. Clin cancer Research: Official J Am Association Cancer Res. 2005;11(8):2947\u201353.","journal-title":"Clin cancer Research: Official J Am Association Cancer Res"},{"key":"4003_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/hel.12405","volume":"22","author":"V Camilo","year":"2017","unstructured":"Camilo V, Sugiyama T, Touati E. Pathogenesis of Helicobacter pylori infection. Helicobacter. 2017;22:1.","journal-title":"Helicobacter"},{"key":"4003_CR27","doi-asserted-by":"crossref","unstructured":"Vogiatzi P, Cassone M, Luzzi I, Lucchetti C, Otvos L. Giordano AJJocb: Helicobacter pylori as a class I carcinogen: physiopathology and management strategies. 2007, 102(2):264\u201373.","DOI":"10.1002\/jcb.21375"},{"issue":"12","key":"4003_CR28","doi-asserted-by":"publisher","first-page":"4375","DOI":"10.1007\/s00253-022-12011-z","volume":"106","author":"L Zhu","year":"2022","unstructured":"Zhu L, Huang Y, Li H, Shao S. Helicobacter pylori promotes gastric cancer progression through the tumor microenvironment. Appl Microbiol Biotechnol. 2022;106(12):4375\u201385.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"4","key":"4003_CR29","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1148\/rg.2021200168","volume":"41","author":"A Bonde","year":"2021","unstructured":"Bonde A, Daly S, Kirsten J, Kondapaneni S, Mellnick V, Menias CO, Katabathina VS. Human gut Microbiota-associated Gastrointestinal malignancies: A comprehensive review. Radiographics: Rev Publication Radiological Soc North Am Inc. 2021;41(4):1103\u201322.","journal-title":"Radiographics: Rev Publication Radiological Soc North Am Inc"},{"issue":"6","key":"4003_CR30","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s11894-009-0070-y","volume":"11","author":"G Sachs","year":"2009","unstructured":"Sachs G, Wen Y, Scott DR. Gastric infection by Helicobacter pylori. Curr Gastroenterol Rep. 2009;11(6):455\u201361.","journal-title":"Curr Gastroenterol Rep"},{"issue":"5","key":"4003_CR31","doi-asserted-by":"publisher","first-page":"639","DOI":"10.4161\/auto.23782","volume":"9","author":"NS Deen","year":"2013","unstructured":"Deen NS, Huang SJ, Gong L, Kwok T, Devenish RJ. The impact of autophagic processes on the intracellular fate of Helicobacter pylori: more tricks from an enigmatic pathogen? Autophagy. 2013;9(5):639\u201352.","journal-title":"Autophagy"},{"issue":"6","key":"4003_CR32","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/hel.12223","volume":"20","author":"NS Deen","year":"2015","unstructured":"Deen NS, Gong L, Naderer T, Devenish RJ, Kwok T. Analysis of the relative contribution of phagocytosis, LC3-Associated phagocytosis, and canonical autophagy during Helicobacter pylori infection of macrophages. Helicobacter. 2015;20(6):449\u201359.","journal-title":"Helicobacter"},{"issue":"16","key":"4003_CR33","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.3748\/wjg.v23.i16.2870","volume":"23","author":"ATB Abadi","year":"2017","unstructured":"Abadi ATB. Strategies used by helicobacter pylori to Establish persistent infection. World J Gastroenterol. 2017;23(16):2870\u201382.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"4003_CR34","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","volume":"124","author":"H Raskov","year":"2021","unstructured":"Raskov H, Orhan A, Christensen JP, G\u00f6genur I. Cytotoxic CD8(+) T cells in cancer and cancer immunotherapy. Br J Cancer. 2021;124(2):359\u201367.","journal-title":"Br J Cancer"},{"issue":"5","key":"4003_CR35","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1002\/jso.24977","volume":"117","author":"SS Nishizuka","year":"2018","unstructured":"Nishizuka SS, Tamura G, Nakatochi M, Fukushima N, Ohmori Y, Sumida C, Iwaya T, Takahashi T, Koeda K. Northern Japan gastric Cancer study C: Helicobacter pylori infection is associated with favorable outcome in advanced gastric cancer patients treated with S-1 adjuvant chemotherapy. J Surg Oncol. 2018;117(5):947\u201356.","journal-title":"J Surg Oncol"},{"issue":"3","key":"4003_CR36","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1093\/annonc\/mdv610","volume":"27","author":"BW Kang","year":"2016","unstructured":"Kang BW, Seo AN, Yoon S, Bae HI, Jeon SW, Kwon OK, Chung HY, Yu W, Kang H, Kim JG. Prognostic value of tumor-infiltrating lymphocytes in Epstein-Barr virus-associated gastric cancer. Ann Oncol. 2016;27(3):494\u2013501.","journal-title":"Ann Oncol"},{"issue":"9","key":"4003_CR37","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1038\/s41416-020-0793-y","volume":"122","author":"Y Kwak","year":"2020","unstructured":"Kwak Y, Koh J, Park Y, Hong YJ, Park KU, Kim HH, Park DJ, Ahn SH, Kim WH, Lee HS. Differential prognostic impact of CD8(+) T cells based on human leucocyte antigen I and PD-L1 expression in microsatellite-unstable gastric cancer. Br J Cancer. 2020;122(9):1399\u2013408.","journal-title":"Br J Cancer"},{"issue":"2","key":"4003_CR38","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1093\/annonc\/mdy547","volume":"30","author":"SJ Luen","year":"2019","unstructured":"Luen SJ, Salgado R, Dieci MV, Vingiani A, Curigliano G, Gould RE, Castaneda C, D\u2019Alfonso T, Sanchez J, Cheng E, et al. Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple-negative breast cancer patients after neoadjuvant chemotherapy. Ann Oncol. 2019;30(2):236\u201342.","journal-title":"Ann Oncol"},{"issue":"1","key":"4003_CR39","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/S1470-2045(16)30631-3","volume":"18","author":"SJ Luen","year":"2017","unstructured":"Luen SJ, Salgado R, Fox S, Savas P, Eng-Wong J, Clark E, Kiermaier A, Swain SM, Baselga J, Michiels S, et al. Tumour-infiltrating lymphocytes in advanced HER2-positive breast cancer treated with Pertuzumab or placebo in addition to trastuzumab and docetaxel: a retrospective analysis of the CLEOPATRA study. Lancet Oncol. 2017;18(1):52\u201362.","journal-title":"Lancet Oncol"},{"issue":"1","key":"4003_CR40","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.canlet.2015.10.009","volume":"370","author":"H Tang","year":"2016","unstructured":"Tang H, Qiao J, Fu YX. Immunotherapy and tumor microenvironment. Cancer Lett. 2016;370(1):85\u201390.","journal-title":"Cancer Lett"},{"issue":"6","key":"4003_CR41","doi-asserted-by":"publisher","first-page":"454","DOI":"10.4161\/gmic.27001","volume":"4","author":"SK Pachathundikandi","year":"2013","unstructured":"Pachathundikandi SK, Tegtmeyer N, Backert S. Signal transduction of Helicobacter pylori during interaction with host cell protein receptors of epithelial and immune cells. Gut Microbes. 2013;4(6):454\u201374.","journal-title":"Gut Microbes"},{"issue":"1","key":"4003_CR42","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1365-2249.2011.04447.x","volume":"166","author":"JM Kim","year":"2011","unstructured":"Kim JM, Kim JS, Yoo DY, Ko SH, Kim N, Kim H, Kim YJ. Stimulation of dendritic cells with Helicobacter pylori vacuolating cytotoxin negatively regulates their maturation via the restoration of E2F1. Clin Exp Immunol. 2011;166(1):34\u201345.","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"4003_CR43","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.chom.2007.11.003","volume":"3","author":"X Sewald","year":"2008","unstructured":"Sewald X, Gebert-Vogl B, Prassl S, Barwig I, Weiss E, Fabbri M, Osicka R, Schiemann M, Busch DH, Semmrich M, et al. Integrin subunit CD18 is the T-lymphocyte receptor for the Helicobacter pylori vacuolating cytotoxin. Cell Host Microbe. 2008;3(1):20\u20139.","journal-title":"Cell Host Microbe"},{"issue":"2","key":"4003_CR44","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/annonc\/mdu450","volume":"26","author":"R Salgado","year":"2015","unstructured":"Salgado R, Denkert C, Demaria S, Sirtaine N, Klauschen F, Pruneri G, Wienert S, Van den Eynden G, Baehner FL, Penault-Llorca F, et al. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an international TILs working group 2014. Annals Oncology: Official J Eur Soc Med Oncol. 2015;26(2):259\u201371.","journal-title":"Annals Oncology: Official J Eur Soc Med Oncol"},{"issue":"3","key":"4003_CR45","first-page":"361","volume":"140","author":"AS Rathore","year":"2014","unstructured":"Rathore AS, Kumar S, Konwar R, Makker A, Negi MP, Goel MM. CD3+, CD4+ & CD8\u2009+\u2009tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast. Indian J Med Res. 2014;140(3):361\u20139.","journal-title":"Indian J Med Res"},{"issue":"8","key":"4003_CR46","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/nnano.2013.142","volume":"8","author":"M Rudchenko","year":"2013","unstructured":"Rudchenko M, Taylor S, Pallavi P, Dechkovskaia A, Khan S, Butler VP Jr., Rudchenko S, Stojanovic MN. Autonomous molecular cascades for evaluation of cell surfaces. Nat Nanotechnol. 2013;8(8):580\u20136.","journal-title":"Nat Nanotechnol"},{"issue":"7505","key":"4003_CR47","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nature13444","volume":"510","author":"K Ali","year":"2014","unstructured":"Ali K, Soond DR, Pineiro R, Hagemann T, Pearce W, Lim EL, Bouabe H, Scudamore CL, Hancox T, Maecker H, et al. Inactivation of PI(3)K p110\u03b4 breaks regulatory T-cell-mediated immune tolerance to cancer. Nature. 2014;510(7505):407\u201311.","journal-title":"Nature"},{"issue":"8","key":"4003_CR48","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1093\/jnci\/djac085","volume":"114","author":"Y Koizumi","year":"2022","unstructured":"Koizumi Y, Ahmad S, Ikeda M, Yashima-Abo A, Espina G, Sugimoto R, Sugai T, Iwaya T, Tamura G, Koeda K, et al. Helicobacter pylori modulated host immunity in gastric Cancer patients with S-1 adjuvant chemotherapy. J Natl Cancer Inst. 2022;114(8):1149\u201358.","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"4003_CR49","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1136\/gutjnl-2020-320839","volume":"69","author":"AC Ford","year":"2020","unstructured":"Ford AC, Yuan Y, Moayyedi P. Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis. Gut. 2020;69(12):2113\u201321.","journal-title":"Gut"},{"key":"4003_CR50","doi-asserted-by":"crossref","unstructured":"Magahis PT, Maron SB, Cowzer D, King S, Schattner M, Janjigian Y, Faleck D, Laszkowska M. Impact of Helicobacter pylori infection status on outcomes among patients with advanced gastric cancer treated with immune checkpoint inhibitors. J Immunother Cancer 2023, 11(10).","DOI":"10.1136\/jitc-2023-007699"},{"key":"4003_CR51","doi-asserted-by":"crossref","unstructured":"Esayas Lelisho M, Akessa GM, Kifle Demissie D, Fikadu Yermosa S, Andargie SA, Tareke SA, Pandey D. Application of parametric shared frailty models to analyze Time-to-Death of gastric Cancer patients. J Gastrointest cancer 2022.","DOI":"10.1007\/s12029-021-00775-y"},{"issue":"1","key":"4003_CR52","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s12957-021-02343-x","volume":"19","author":"L Wang","year":"2021","unstructured":"Wang L, Wang J, Li S, Bai F, Xie H, Shan H, Liu Z, Ma T, Tang X, Tang H, et al. The effect of Helicobacter pylori eradication on prognosis of postoperative early gastric cancer: a multicenter study. World J Surg Oncol. 2021;19(1):285.","journal-title":"World J Surg Oncol"},{"issue":"3","key":"4003_CR53","doi-asserted-by":"publisher","first-page":"e243812","DOI":"10.1001\/jamanetworkopen.2024.3812","volume":"7","author":"Z Zhao","year":"2024","unstructured":"Zhao Z, Zhang R, Chen G, Nie M, Zhang F, Chen X, Lin J, Chen Z, Lin F, Wei C, et al. Anti-Helicobacter pylori treatment in patients with gastric Cancer after radical gastrectomy. JAMA Netw Open. 2024;7(3):e243812.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"4003_CR54","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/j.1365-2249.2010.04217.x","volume":"161","author":"Y-Y Wu","year":"2010","unstructured":"Wu Y-Y, Lin C-W, Cheng K-S, Lin C, Wang Y-M, Lin I-T, Chou Y-H, Hsu P-N. Increased programmed death-ligand-1 expression in human gastric epithelial cells in Helicobacter pylori infection. Clin Exp Immunol. 2010;161(3):551\u20139.","journal-title":"Clin Exp Immunol"},{"key":"4003_CR55","doi-asserted-by":"crossref","unstructured":"Zhu Y, Zhu F, Ba H, Chen J, Bian X. Helicobacter pylori infection and PD-L1 expression in gastric cancer: a meta-analysis. Eur J Clin Invest 2022:e13880.","DOI":"10.1111\/eci.13880"},{"issue":"1","key":"4003_CR56","doi-asserted-by":"publisher","first-page":"e1007468","DOI":"10.1371\/journal.ppat.1007468","volume":"15","author":"L Holokai","year":"2019","unstructured":"Holokai L, Chakrabarti J, Broda T, Chang J, Hawkins JA, Sundaram N, Wroblewski LE, Peek RM Jr., Wang J, Helmrath M, et al. Increased programmed Death-Ligand 1 is an early epithelial cell response to Helicobacter pylori infection. PLoS Pathog. 2019;15(1):e1007468.","journal-title":"PLoS Pathog"},{"issue":"5636","key":"4003_CR57","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1126\/science.1086871","volume":"301","author":"B Gebert","year":"2003","unstructured":"Gebert B, Fischer W, Weiss E, Hoffmann R, Haas R. Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Sci (New York NY). 2003;301(5636):1099\u2013102.","journal-title":"Sci (New York NY)"},{"issue":"11","key":"4003_CR58","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1084\/jem.192.11.1601","volume":"192","author":"K Ogura","year":"2000","unstructured":"Ogura K, Maeda S, Nakao M, Watanabe T, Tada M, Kyutoku T, Yoshida H, Shiratori Y, Omata M. Virulence factors of Helicobacter pylori responsible for gastric diseases in Mongolian gerbil. J Exp Med. 2000;192(11):1601\u201310.","journal-title":"J Exp Med"},{"issue":"5","key":"4003_CR59","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1172\/JCI130015","volume":"130","author":"M Palrasu","year":"2020","unstructured":"Palrasu M, Zaika E, El-Rifai W, Garcia-Buitrago M, Piazuelo MB, Wilson KT, Peek RM Jr., Zaika AI. Bacterial CagA protein compromises tumor suppressor mechanisms in gastric epithelial cells. J Clin Invest. 2020;130(5):2422\u201334.","journal-title":"J Clin Invest"},{"issue":"2","key":"4003_CR60","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1086\/367807","volume":"187","author":"S Yamazaki","year":"2003","unstructured":"Yamazaki S, Yamakawa A, Ito Y, Ohtani M, Higashi H, Hatakeyama M, Azuma T. The CagA protein of Helicobacter pylori is translocated into epithelial cells and binds to SHP-2 in human gastric mucosa. J Infect Dis. 2003;187(2):334\u20137.","journal-title":"J Infect Dis"},{"issue":"2","key":"4003_CR61","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1053\/j.gastro.2006.05.001","volume":"131","author":"R Rad","year":"2006","unstructured":"Rad R, Brenner L, Bauer S, Schwendy S, Layland L, da Costa CP, Reindl W, Dossumbekova A, Friedrich M, Saur D, et al. CD25+\/Foxp3\u2009+\u2009T cells regulate gastric inflammation and Helicobacter pylori colonization in vivo. Gastroenterology. 2006;131(2):525\u201337.","journal-title":"Gastroenterology"},{"issue":"36","key":"4003_CR62","doi-asserted-by":"publisher","first-page":"12753","DOI":"10.3748\/wjg.v20.i36.12753","volume":"20","author":"TT Lina","year":"2014","unstructured":"Lina TT, Alzahrani S, Gonzalez J, Pinchuk IV, Beswick EJ, Reyes VE. Immune evasion strategies used by Helicobacter pylori. World J Gastroenterol. 2014;20(36):12753\u201366.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"4003_CR63","doi-asserted-by":"publisher","first-page":"316","DOI":"10.4049\/jimmunol.1302476","volume":"192","author":"R Kaebisch","year":"2014","unstructured":"Kaebisch R, Mej\u00edas-Luque R, Prinz C, Gerhard M. Helicobacter pylori cytotoxin-associated gene A impairs human dendritic cell maturation and function through IL-10-mediated activation of STAT3. J Immunol (Baltimore Md: 1950). 2014;192(1):316\u201323.","journal-title":"J Immunol (Baltimore Md: 1950)"},{"issue":"9","key":"4003_CR64","doi-asserted-by":"publisher","first-page":"5837","DOI":"10.4049\/jimmunol.0901206","volume":"183","author":"HM Algood","year":"2009","unstructured":"Algood HM, Allen SS, Washington MK, Peek RM Jr., Miller GG, Cover TL. Regulation of gastric B cell recruitment is dependent on IL-17 receptor A signaling in a model of chronic bacterial infection. J Immunol (Baltimore Md: 1950). 2009;183(9):5837\u201346.","journal-title":"J Immunol (Baltimore Md: 1950)"},{"issue":"9","key":"4003_CR65","doi-asserted-by":"publisher","first-page":"4692","DOI":"10.4049\/jimmunol.168.9.4692","volume":"168","author":"AP Gobert","year":"2002","unstructured":"Gobert AP, Cheng Y, Wang JY, Boucher JL, Iyer RK, Cederbaum SD, Casero RA Jr., Newton JC, Wilson KT. Helicobacter pylori induces macrophage apoptosis by activation of arginase II. J Immunol (Baltimore Md: 1950). 2002;168(9):4692\u2013700.","journal-title":"J Immunol (Baltimore Md: 1950)"},{"issue":"4","key":"4003_CR66","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1128\/IAI.71.4.1755-1762.2003","volume":"71","author":"A Lundgren","year":"2003","unstructured":"Lundgren A, Suri-Payer E, Enarsson K, Svennerholm AM, Lundin BS. Helicobacter pylori-specific CD4\u2009+\u2009CD25high regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals. Infect Immun. 2003;71(4):1755\u201362.","journal-title":"Infect Immun"},{"issue":"5","key":"4003_CR67","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1093\/jnci\/djh057","volume":"96","author":"W Ye","year":"2004","unstructured":"Ye W, Held M, Lagergren J, Engstrand L, Blot WJ, McLaughlin JK, Nyr\u00e9n O. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Cancer Inst. 2004;96(5):388\u201396.","journal-title":"J Natl Cancer Inst"},{"key":"4003_CR68","doi-asserted-by":"publisher","first-page":"1282680","DOI":"10.3389\/fimmu.2024.1282680","volume":"15","author":"M Anthofer","year":"2024","unstructured":"Anthofer M, Windisch M, Haller R, Ehmann S, Wrighton S, Miller M, Schernthanner L, Kufferath I, Schauer S, Jelu\u0161i\u0107 B, et al. Immune evasion by proteolytic shedding of natural killer group 2, member D ligands in Helicobacter pylori infection. Front Immunol. 2024;15:1282680.","journal-title":"Front Immunol"},{"key":"4003_CR69","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3389\/fcimb.2017.00417","volume":"7","author":"N Li","year":"2017","unstructured":"Li N, Tang B, Jia YP, Zhu P, Zhuang Y, Fang Y, Li Q, Wang K, Zhang WJ, Guo G, et al. Helicobacter pylori CagA protein negatively regulates autophagy and promotes inflammatory response via c-Met-PI3K\/Akt-mTOR signaling pathway. Front Cell Infect Microbiol. 2017;7:417.","journal-title":"Front Cell Infect Microbiol"},{"issue":"7","key":"4003_CR70","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1084\/jem.20090207","volume":"206","author":"L Wang","year":"2009","unstructured":"Wang L, Yi T, Kortylewski M, Pardoll DM, Zeng D, Yu H. IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway. J Exp Med. 2009;206(7):1457\u201364.","journal-title":"J Exp Med"},{"issue":"5","key":"4003_CR71","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.4049\/jimmunol.176.5.3000","volume":"176","author":"S Das","year":"2006","unstructured":"Das S, Suarez G, Beswick EJ, Sierra JC, Graham DY, Reyes VE. Expression of B7-H1 on gastric epithelial cells: its potential role in regulating T cells during Helicobacter pylori infection. J Immunol (Baltimore Md: 1950). 2006;176(5):3000\u20139.","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"4003_CR72","doi-asserted-by":"publisher","first-page":"38362","DOI":"10.1038\/srep38362","volume":"6","author":"L Shen","year":"2016","unstructured":"Shen L, Gao Y, Liu Y, Zhang B, Liu Q, Wu J, Fan L, Ou Q, Zhang W, Shao L. PD-1\/PD-L pathway inhibits M.tb-specific CD4(+) T-cell functions and phagocytosis of macrophages in active tuberculosis. Sci Rep. 2016;6:38362.","journal-title":"Sci Rep"},{"issue":"3","key":"4003_CR73","doi-asserted-by":"publisher","first-page":"e12571","DOI":"10.1111\/cpr.12571","volume":"52","author":"R Zhao","year":"2019","unstructured":"Zhao R, Song Y, Wang Y, Huang Y, Li Z, Cui Y, Yi M, Xia L, Zhuang W, Wu X, et al. PD-1\/PD-L1 Blockade rescue exhausted CD8\u2009+\u2009T cells in Gastrointestinal stromal tumours via the PI3K\/Akt\/mTOR signalling pathway. Cell Prolif. 2019;52(3):e12571.","journal-title":"Cell Prolif"},{"issue":"1","key":"4003_CR74","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12943-021-01398-4","volume":"20","author":"Z Liu","year":"2021","unstructured":"Liu Z, Wang T, She Y, Wu K, Gu S, Li L, Dong C, Chen C, Zhou Y. N(6)-methyladenosine-modified circIGF2BP3 inhibits CD8(+) T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer. Mol Cancer. 2021;20(1):105.","journal-title":"Mol Cancer"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04003-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04003-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04003-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T11:02:51Z","timestamp":1748602971000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-04003-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4003"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04003-w","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]},"assertion":[{"value":"14 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in study involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee(s) and with the Helsinki Declaration (as revised in 2013). The study was reviewed and approved by the Ethics Committee of the First Affiliated Hospital of Nanjing Medical University (approval number: 2024-SRFA-459). As this was a retrospective study and did not include any potentially identifiable patient data, informed consent was waived by the Ethics Committee of the First Affiliated Hospital of Nanjing Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"420"}}